Brief: Cornerstone Pharmaceuticals Consummated Restructuring Of Its Outstanding Debt And Equity Interests
March 13 (Reuters) - Rafael Holdings Inc RFL.N :
* CORNERSTONE PHARMACEUTICALS: ON MARCH 13 CONSUMMATED A
RESTRUCTURING OF ITS OUTSTANDING DEBT AND EQUITY INTERESTS
* CORNERSTONE PHARMACEUTICALS:CONVERTED ABOUT $29.2 MILLION
OF
OUTSTANDING DEBT OWED TO IT BY CORNERSTONE UNDER LINE OF CREDIT
AGREEMENT ENTERED INTO IN 2021
Source text for Eikon: ID:n0001213900-24-022185
Further company coverage: RFL.N
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Rafael Holdings
See all newsBrief: Rafael Holdings Announces Topline Results From The Pivotal Phase 3 Transportnpc™ Study Of Trappsol® Cyclo™ In Niemann-Pick Disease Type C (Npc)
Israel expects new air defence orders from Europe due to Russia concerns
Biotech firm Rafael's Q3 net loss narrows; set to submit NDA for Trappsol Cyclo in H2
Rafael Holdings Q2 net loss widens on consolidation of Cyclo Therapeutic's costs
Brief: Rafael Holdings Q2 Net Income USD -6.327 Million